Nine Square Therapeutics

Biotechnology ResearchCalifornia, United States11-50 Employees

Nine Square Therapeutics is a biotechnology research company that combines machine learning-driven image-based cell profiling with chemistry and computational science to accelerate the development of new drugs. Its focus is on creating first-in-class candidates targeting the autophagy/lysosomal pathway, with the aim of addressing severe neurodegenerative diseases that have historically posed treatment challenges. The company is developing a diversified portfolio of preclinical programs, with lead optimization progressing toward IND-enabling studies, reflecting a goal of advancing therapeutics efficiently from discovery to early clinical development. Based in South San Francisco, California, Nine Square was founded through collaboration between ATP, a life sciences venture capital firm, and UCSF scientists, situating it within a research-oriented biotech ecosystem.

Nine Square’s work targets genetically validated pathways implicated in neurodegeneration, positioning it within the biotechnology research industry as an early-stage drug discovery entity leveraging interdisciplinary methods to identify and optimize novel small molecules. Its activities are framed around advancing multiple programs through preclinical development, with recent leadership appointments indicating organizational growth and strategic direction. The company operates from a San Francisco area hub, aligning with a regional concentration of biotech innovation and venture activity.

Sign up for free to view info

Email Format Employee directory